Thummel, Kenneth E.

ROLE OF ITRACONAZOLE METABOLITES IN CYP3A4 INHIBITION

Isoherranen, N., Kunze, K. L., Allen, K. E., Nelson, W. L., & Thummel, K. E. (2004) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismDrug-Induced Hepatotoxicity and Protection

Cited by 276

Drug metabolism and transport during pregnancy: how does drug disposition change during pregnancy and what are the mechanisms that cause such changes?

Isoherranen, N., & Thummel, K. E. (2013) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismPregnancy and Medication Impact

Cited by 239

Symposium Article: Molecular and Physical Mechanisms of First-Pass Extraction

Hall, S. D., Thummel, K. E., Watkins, P. B., Lown, K. S., Benet, L. Z., Paine, M. F., Mayo, R. R., Turgeon, D. K., Bailey, D. G., Fontana, R. J., et al. (1999) · Drug Metabolism and Disposition

Pharmacogenetics and Drug MetabolismDrug Transport and Resistance Mechanisms

Cited by 109

Implementing Precision Medicine: The Ethical Challenges

Korngiebel, D. M., Thummel, K. E., & Burke, W. (2017) · Trends in Pharmacological Sciences

Ethics and bioethics in healthcareMedical and Health Sciences Research

Cited by 58

Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro ‐ In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail

Nguyen, J. T., Tian, D., Tanna, R. S., Hadi, D. L., Bansal, S., Calamia, J. C., Arian, C. M., Shireman, L. M., Molnár, B., Horváth, M., et al. (2021) · Clinical Pharmacology & Therapeutics

Drug Transport and Resistance MechanismsPharmacogenetics and Drug Metabolism

Cited by 40